Traitement en cours

Veuillez attendre...

PATENTSCOPE sera indisponible durant quelques heures pour des raisons de maintenance le dimanche 05.04.2020 à 10:00 AM CEST
Paramétrages

Paramétrages

1. WO2012006315 - PROCÉDÉS DE MODULATION IMMUNITAIRE

Numéro de publication WO/2012/006315
Date de publication 12.01.2012
N° de la demande internationale PCT/US2011/043020
Date du dépôt international 06.07.2011
CIB
A61K 31/165 2006.01
ANÉCESSITÉS COURANTES DE LA VIE
61SCIENCES MÉDICALE OU VÉTÉRINAIRE; HYGIÈNE
KPRÉPARATIONS À USAGE MÉDICAL, DENTAIRE OU POUR LA TOILETTE
31Préparations médicinales contenant des ingrédients actifs organiques 
16Amides, p.ex. acides hydroxamiques
165ayant des cycles aromatiques, p.ex. colchicine, aténolol, progabide
CPC
A61K 31/166
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
16Amides, e.g. hydroxamic acids
165having aromatic rings, e.g. colchicine, atenolol, progabide
166having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
A61K 31/167
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
16Amides, e.g. hydroxamic acids
165having aromatic rings, e.g. colchicine, atenolol, progabide
167having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
A61K 31/197
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
19Carboxylic acids, e.g. valproic acid
195having an amino group
197the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
A61K 31/505
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
495having six-membered rings with two ; or more; nitrogen atoms as the only ring heteroatoms, e.g. piperazine ; or tetrazines
505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
A61P 1/02
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
1Drugs for disorders of the alimentary tract or the digestive system
02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
Y02A 50/473
YSECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
50in human health protection
30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
46Medical treatment of waterborne diseases characterized by the agent
468The waterborne disease being caused by a bacteria
473the bacteria being Escherichia coli, i.e. E. coli Infection
Déposants
  • POLYMEDIX, INC. [US/US]; 170 N. Radnor-Chester Road Suite 300 Radnor, PA 19087-5221, US (AllExceptUS)
  • UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY [US/US]; One World's Fair Drive Suite 2100 Somerset, NJ 08873, US (AllExceptUS)
  • SCOTT, Richard, W. [US/US]; US (UsOnly)
  • DIAMOND, Gill [US/US]; US (UsOnly)
Inventeurs
  • SCOTT, Richard, W.; US
  • DIAMOND, Gill; US
Mandataires
  • LEGAARD, Paul, K.; Peper Hamilton LLP 400 Berwyn Park 899 Cassatt Road Bewyn, PA 19312-1183, US
Données relatives à la priorité
61/362,08807.07.2010US
Langue de publication anglais (EN)
Langue de dépôt anglais (EN)
États désignés
Titre
(EN) METHODS OF IMMUNE MODULATION
(FR) PROCÉDÉS DE MODULATION IMMUNITAIRE
Abrégé
(EN)
The present invention provides compounds and compositions thereof that modulate the immune system.
(FR)
La présente invention concerne des composés et des compositions les comprenant qui modulent le système immunitaire.
Également publié en tant que
IL224149
RU2013105255
UAa201301476
Dernières données bibliographiques dont dispose le Bureau international